FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085325 [Registered on: 22/04/2025] Trial Registered Prospectively
Last Modified On: 03/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Use Of Karpaskulatthikadi Pottali Sweda In Amavata 
Scientific Title of Study   An Open Randomized Controlled Clinical Trial Of Karpaskulatthikadi Pottali Sweda In Amavata With Special Reference To Rheumatoid Arthritis. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anagha Sanjay Patil 
Designation  PG Scholar 
Affiliation  Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta 
Address  Department Of Panchakarma Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta 416301, Sangli Maharashtra, India.

Sangli
MAHARASHTRA
416301
India 
Phone  8975899937  
Fax    
Email  anagha.patil15@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shankar Mane 
Designation  Professor 
Affiliation  Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta 
Address  Department Of Panchakarma Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta 416301, Sangli Maharashtra, India.

Sangli
MAHARASHTRA
416301
India 
Phone  9922454406  
Fax    
Email  shnkrmane@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shankar Mane 
Designation  Professor 
Affiliation  Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta 
Address  Department Of Panchakarma Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta 416301, Sangli Maharashtra, India.

Sangli
MAHARASHTRA
416301
India 
Phone  9922454406  
Fax    
Email  shnkrmane@gmail.com  
 
Source of Monetary or Material Support  
Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta Tal Walwa Dist Sangli Maharashtra 416301 
 
Primary Sponsor  
Name  Dr Anagha Sanjay Patil 
Address  OPD no 9 , Panchakarma OPD , Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta 416301 , Tal-Walwa, Dist-Sangli , Maharashtra, Inia. 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anagha Sanjay Patil  Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center, Ashta   Department Of Panchakarma, OPD/IPD Of panchakarma, Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center, Ashta
Sangli
MAHARASHTRA 
8975899937

anagha.patil15@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethical Committee OfHon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center, Ashta   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M069||Rheumatoid arthritis, unspecified. Ayurveda Condition: AMAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-sa~gkarasvedaH, संकरस्वेदः (Procedure Reference: Charak Samhita, Sutrasthan, Procedure details: Sankar svedana will given OD for 7 days )
(1) Medicine Name: karpasbeejadi cjurna, kanji, Reference: Bhaishajya Ratnavali, Route: Topical, Dosage Form: Churna/ Powder, Dose: 200(g), Frequency: od, Duration: 7 Days
2Comparator ArmProcedure-sa~gkarasvedaH, संकरस्वेदः (Procedure Reference: Charak Samhita Sutrasthan, Procedure details: Sankar svedana will be given OD for 7 days)
(1) Medicine Name: valuka, Reference: Bhaishajya Ratnavali, Route: Topical, Dosage Form: Churna/ Powder, Dose: 200(g), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1. Patient having the signs and symptoms of Amavata; Sandhishool, Sandhishoth, Sparshasahtva, Sandhi Stabhata, Jwara
2. Patient will be selected irrespective of gender, occupation, and habitat, religion.
3. Patient fit for Pottali Sweda.
4. Chronicity less than 5 yrs.
5. First and second stage of Rheumatoid Arthritis 
 
ExclusionCriteria 
Details  1. Third and Fourth stage of Rheumatoid Arthritis 2. Juvenile Rheumatoid Arthritis
3. Skin diseases, Infectious disease like Osteomyelitis, tuberculosis, Malignancy.
4. Any surgical condition such as Patient with trauma or Accident, fracture, any open wound.
5. Patients with Sandhi Vakrata.
6. Pregnant women, lactating mothers
7. Steroid dependent.
8. Patients is on NSAID. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Karpaskulstthikadi Pottali Sweda Is Effective In The Management Of Amavata  7 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Valuka Pottali Sweda Is Effective In The Management Of Amavata  7 Days 
 
Target Sample Size   Total Sample Size="62"
Sample Size from India="62" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details
Modification(s)  
N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
Rheumatoid Arthritis is a chronic autoimmune disease that causes inflammation and it primarily affects joints, leading to disability and reduced quality of life. It is more prevalent in women, with a global prevalence ranging from 0.3 – 2.1% . It is a genetic disorder. Rheumatoid Arthritis causes inflammation with Sign symptoms including pain, swelling, tenderness of joints, joint stiffness, fatigue, fever, loss of appetite. Above mentioned sign and symptoms of Rheumatoid Arthritis can be correlated with Amavata. In Ayurveda, Amavata first explained in Madhavnidana by Madhavkara. He also explained that samprapti of almost all diseases begin with the agnimandya which leads  to formation of Ama, this ama is a most important causative factor for various diseases . Amavata is a disease in which vitiation of Vata Dosha and accumulation of Ama take place in joints. Whenever that Ama gets localized in the body tissue or joints, it can lead to production of pain, stiffness, swelling, tenderness in the related joints. It is the disease of Madhyam rogamarg Asthi and Sandhi are the chief site for the manifestation of cardinal symptoms like Angmard, Sandhishool, Shandhishoth and Sandhigraha. Bhaishajya Ratnavali has explained chikitsa of Amavata in detail including its specific line of treatment like Langhana, Swedana, Deepana, Pachana, Snehpana, Virechana and Basti from above, Swedana, Snehapana, Virechana, Basti are Panchakarma procedures which are traditional ayurvedic treatment that plays a crucial role in managing Aamvata. In Ayurvedic treatment principles for Amavata involve therapeutic methods like Swedana.
Here Karpaskulatthikadi Pottali Sweda include karpasthi, kulattha, til, yava, erandamula, Atasi, varshabhu, shanabeej, kanji after making Pottali, Sweda will be given to sarvang for 7 days. So, it will help in reduction of samavata which ultimately reduces stiffness, pain, swelling of joints. Also, it is affordable, easy for administration.
 
Close